Connect
lidERA, (Giredestrant) in Trial 3.
I accessed information from The 2025 San Antonio Breast Cancer Symposium, (sabcs.org) and found information about a new aromatase inhibitor named lidERA. It sounds as if it could work better, and be more tolerable than the others. aacr.org. Information about patients with BRCA mutations, and a risk-based screening study called WISDOM.
Like
Helpful
HugInterested in more discussions like this? Go to the Breast Cancer Support Group.
Connect
Giredestrant does seem promising based on what was presented at the Symposium. Almost a game changer so high hopes for this one. I checked to see if the clinical trial was accepting new enrollees and it was not. Since it is in Phase 3 of clinical trials, I'm estimating it could be about 2 more years before it is widely available, but that's a guess on my part.
It will be interesting to learn what the side effects are in the Phase 4.